IP Library Granted Patent US 6,993,391
Granted Patent B2
US 6,993,391 · App. 10/446,567 · Granted Jan 31, 2006

Acute and chronic electrical signal therapy for obesity

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,993,391
App. No.
10/446,567
Granted
Jan 31, 2006
Kind
B2
Abstract

Apparatus is provided for treating a condition such as obesity. The apparatus includes a set of one or more electrodes, which are adapted to be applied to one or more respective sites in a vicinity of a body of a stomach of a patient. A control unit is adapted to drive the electrode set to apply to the body of the stomach a signal, configured such that application thereof increases a level of contraction of muscle tissue of the body of the stomach, and decreases a cross-sectional area of a portion of the body of the stomach for a substantially continuous period greater than about 3 seconds.

Claims (61)

1. Apparatus for treating a condition, comprising:

a set of one or more electrodes, adapted to be applied to one or more respective sites in a vicinity of a stomach of a patient; and

a control unit, adapted to drive the electrode set to apply an Excitable-Tissue Control (ETC) signal to the sites, configured such that application thereof decreases a cross-sectional area of at least a portion of the stomach,

wherein the control unit is adapted to configure a timing parameter of the ETC signal responsive to timing of natural gastric electrical activity.

2. Apparatus according to claim 1 , wherein the electrode set is adapted to be applied in contact with muscle tissue of the stomach.

3. Apparatus according to claim 1 , wherein the control unit is adapted to configure the ETC signal such that application thereof decreases a volume of the stomach.

4. Apparatus according to claim 1 , wherein the control unit is adapted to drive the electrode set to apply the ETC signal as a series of biphasic pulses.

5. Apparatus according to claim 1 , wherein the control unit is adapted to configure the ETC signal to have a duration of at least about 1 second.

6. Apparatus according to claim 5 . wherein the control unit is adapted to configure the ETC signal to have a duration of at least about 3 seconds.

7. Apparatus according to claim 1 , wherein the control unit is adapted to drive the electrode set in accordance with a schedule programmed into the control unit.

8. Apparatus for treating a condition, comprising:

a set of one or more electrodes, adapted to be applied to one or more respective sites in a vicinity of a stomach of a patient; and

a control unit, adapted to drive the electrode set to apply an Excitable-Tissue Control (ETC) signal to the sites, configured such that application thereof decreases a cross-sectional area of at least a portion of the stomach,

wherein the control unit is adapted to receive a patient signal, input by the patient, and to drive the electrode set responsive to the patient signal.

9. Apparatus according to claim 8 , wherein the electrode set is adapted to be applied in contact with muscle tissue of the stomach.

10. Apparatus according to claim 8 , wherein the control unit is adapted to configure the ETC signal such that application thereof decreases a volume of the stomach.

11. Apparatus according to claim 8 , wherein the control unit is adapted to drive the electrode set to apply the ETC signal as a series of biphasic pulses.

12. Apparatus according to claim 8 , wherein the control unit is adapted to configure the ETC signal to have a duration of at least about 1 second.

13. Apparatus according to claim 12 , wherein the control unit is adapted to configure the ETC signal to have a duration of at least about 3 seconds.

14. Apparatus according to claim 8 , wherein the control unit is adapted to drive the electrode set in accordance with a schedule programmed into the control unit.

15. Apparatus for treating a condition, comprising:

a set of one or more electrodes, adapted to be applied to one or more respective sites in a vicinity of a stomach of a patient;

a control unit, adapted to drive the electrode set to apply an Excitable-Tissue Control (ETC) signal to the sites, configured such that application thereof decreases a cross-sectional area of at least a portion of the stomach; and

a second set of one or more electrodes, adapted to be applied to one or more respective sites in a vicinity of a lower-esophageal sphincter of the patient, wherein the control unit is adapted to drive the second electrode set to apply a sphincter-control signal to the sphincter, configured such that application thereof increases a contraction force generated by the sphincter.

16. Apparatus for treating a condition, comprising:

exactly one set of one or more electrodes, adapted to be applied to one or more respective sites in a vicinity of a body of a stomach of a patient, the one or more respective sites generally arranged in a plane substantially perpendicular to a longitudinal axis of the stomach; and

a control unit, adapted to drive the electrode set to apply to the body of the stomach, substantially in the plane, a signal configured such that application thereof increases a level of contraction of muscle tissue of the body of the stomach, and decreases a cross-sectional area of a portion of the body of the stomach substantially in the plane for a substantially continuous period greater than about 3 seconds.

17. Apparatus according to claim 16 , wherein the electrode set is adapted to be applied in contact with muscle tissue of the stomach.

18. Apparatus according to claim 16 , wherein the control unit is adapted to configure the signal such that application thereof decreases a volume of the stomach.

19. Apparatus according to claim 16 , wherein the control unit is adapted to drive the electrode set in accordance with a schedule programmed into the control unit.

20. A method for treating a condition, comprising:

applying an Excitable-Tissue Control (ETC) signal to one or more sites in a vicinity of a stomach of a patient; and

configuring the ETC signal such that application thereof to the one or more sites decreases a cross-sectional area of at least a portion of the stomach,

wherein configuring the signal comprises configuring a timing parameter of the signal responsive to timing of natural gastric electrical activity.

21. A method according to claim 20 , wherein applying the signal comprises applying the signal to muscle tissue of the stomach.

22. A method according to claim 20 , wherein configuring the signal comprises configuring the signal such that application thereof decreases a volume of the stomach.

23. A method according to claim 20 , wherein configuring the signal comprises configuring the signal as a series of biphasic pulses.

24. A method according to claim 20 , wherein configuring the signal comprises configuring the signal to have a duration of at least about 1 second.

25. A method according to claim 24 , wherein configuring the signal comprises configuring the signal to have a duration of at least about 3 seconds.

26. A method according to claim 20 , wherein configuring the signal comprises configuring the signal in accordance with a schedule.

27. A method for treating a condition, comprising:

applying an Excitable-Tissue Control (ETC) signal to one or more sites in a vicinity of a stomach of a patient;

configuring the ETC signal such that application thereof to the one or more sites decreases a cross-sectional area of at least a portion of the stomach;

applying a sphincter-control signal to one or more sites in a vicinity of a lower-esophageal sphincter of the patient; and

configuring the sphincter-control signal such that application thereof increases a contraction force generated by the sphincter.

28. A method for treating a condition, comprising:

applying an Excitable-Tissue Control (ETC) signal to one or more sites in a vicinity of a stomach of a patient;

configuring the ETC signal such that application thereof to the one or more sites decreases a cross-sectional area of at least a portion of the stomach; and

receiving a patient signal input by the patient, wherein configuring the ETC signal comprises configuring the ETC signal responsive to the patient signal.

29. A method according to claim 28 , wherein applying the signal comprises applying the signal to muscle tissue of the stomach.

30. A method according to claim 28 , wherein configuring the signal comprises configuring the signal such that application thereof decreases a volume of the stomach.

31. A method according to claim 28 , wherein configuring the signal comprises configuring the signal as a series of biphasic pulses.

32. A method according to claim 28 , wherein configuring the signal comprises configuring the signal to have a duration of at least about 1 second.

33. A method according to claim 32 , wherein configuring the signal comprises configuring the signal to have a duration of at least about 3 seconds.

34. A method according to claim 28 , wherein configuring the signal comprises configuring the signal in accordance with a schedule.

35. A method for treating a condition, comprising:

applying a signal to exactly one set of one or more sites in a vicinity of a body of a stomach of a patient, the one or more sites generally arranged in a plane substantially perpendicular to a longitudinal axis of the stomach; and

configuring the signal such that application thereof to the one or more sites increases a level of contraction of muscle tissue of a portion of the body of the stomach substantially in the plane, and decreases a cross-sectional area of the portion for a substantially continuous period greater than about 3 seconds.

36. A method according to claim 35 , wherein applying the signal comprises applying the signal to muscle tissue of the body of the stomach.

37. A method according to claim 35 , wherein configuring the signal comprises configuring the signal such that application thereof decreases a volume of the body of the stomach.

38. A method according to claim 35 , wherein configuring the signal comprises configuring the signal in accordance with a schedule.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2019
From: METACURE LIMITED
To: TYLERTON INTERNATIONAL, INC.
Reel/Frame 051391/0676 →
ASSIGNMENT OF TRADEMARK AND PATENT SECURITY AGREEMENT Recorded Apr 8, 2015
From: MEDINVEST CAPITAL S.A.R.L.; MORGAN STANLEY BANK INTERNATIONAL LIMITED
To: SANDLEFORD PARK LIMITED, AS SECURITY AGENT
Reel/Frame 035387/0041 →